Russian Association of Pharmacy Networks, 20 September 2023
DSM Group has analysed the market of anti-inflammatory, antipyretic, and analgesic drugs for the first half of 2023. According to the released data, the rouble share of Russian-made drugs is growing annually: at the end of the first half of 2023, it amounted to 41%. About 60% of sales are made up of drugs of leading Russian manufacturers.
OTC drugs account for 82% of antipyretics, analgesics, and NSAIDs. The top three drugs in terms of physical consumption are:
acetylsalicylic acid + caffeine + paracetamol (16.1% of all packages), paracetamol (14.4%), acetylsalicylic acid (9.7%).
Pharmstandard is the leader in physical sales, thanks to its first positions in such INNs and combinations as acetylsalicylic acid + caffeine + paracetamol, paracetamol, acetylsalicylic acid, and sodium metamizole (in the price segment of up to 50 roubles per package).
| Back | Print out |
